These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 1646284
1. Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells. Daikoku T, Yamamoto N, Maeno K, Nishiyama Y. J Gen Virol; 1991 Jun; 72 ( Pt 6)():1441-4. PubMed ID: 1646284 [Abstract] [Full Text] [Related]
2. The sources of thymidine nucleotides for virus DNA synthesis in herpes simplex virus type 2-infected cells. Nutter LM, Grill SP, Cheng YC. J Biol Chem; 1985 Oct 25; 260(24):13272-5. PubMed ID: 2997161 [Abstract] [Full Text] [Related]
3. Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. Marcello A, Pizzato M, Loregian A, Palù G. Biochem Soc Trans; 1995 Nov 25; 23(4):627S. PubMed ID: 8654812 [No Abstract] [Full Text] [Related]
4. Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds? Nutter LM, Grill SP, Cheng YC. Biochem Pharmacol; 1985 Mar 15; 34(6):777-80. PubMed ID: 2983736 [Abstract] [Full Text] [Related]
12. The herpes simplex virus ribonucleotide reductase is required for ocular virulence. Brandt CR, Kintner RL, Pumfery AM, Visalli RJ, Grau DR. J Gen Virol; 1991 Sep 15; 72 ( Pt 9)():2043-9. PubMed ID: 1654368 [Abstract] [Full Text] [Related]
13. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. Yamada Y, Kimura H, Morishima T, Daikoku T, Maeno K, Nishiyama Y. J Infect Dis; 1991 Dec 15; 164(6):1091-7. PubMed ID: 1659596 [Abstract] [Full Text] [Related]
14. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway. Aduma PJ, Gupta SV, Stuart AL, Tourigny G. Biochem Cell Biol; 1991 Dec 15; 69(5-6):409-14. PubMed ID: 1654943 [Abstract] [Full Text] [Related]
15. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. De Clercq E, Bères J, Bentrude WG. Mol Pharmacol; 1987 Aug 15; 32(1):286-92. PubMed ID: 3039343 [Abstract] [Full Text] [Related]
16. Deoxyribonucleoside triphosphate pools in cells infected with deoxypyrimidine kinaseless herpes simplex virus. Jamieson AT, Bjursell G. J Gen Virol; 1976 Apr 15; 31(1):115-23. PubMed ID: 177723 [Abstract] [Full Text] [Related]
17. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors. Aduma PJ, Gupta SV, De Clercq E. Antiviral Res; 1990 Mar 15; 13(3):111-25. PubMed ID: 2162147 [Abstract] [Full Text] [Related]
18. Ribonucleotide reductase from herpes simplex virus (types 1 and 2) infected and uninfected KB cells: properties of the partially purified enzymes. Ponce de Leon M, Eisenberg RJ, Cohen GH. J Gen Virol; 1977 Jul 15; 36(1):163-73. PubMed ID: 18550 [Abstract] [Full Text] [Related]
19. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1. Karlsson A, Harmenberg J. Antimicrob Agents Chemother; 1988 Jul 15; 32(7):1100-2. PubMed ID: 2847642 [Abstract] [Full Text] [Related]